Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human CEMIP, N-His

Recombinant Human CEMIP, N-His from ProteoGenix; catalogue ARO-P13224; research use only.

SKU:
ABM143663-1
Manufacturer SKU
ARO-P13224
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human CEMIP (Cell Migration-Inducing Protein) is a protein that plays a crucial role in cell migration and invasion. It is a transmembrane glycoprotein that is encoded by the CEMIP gene. This protein has been extensively studied and has shown promising potential in various biological processes. In this article, we will provide a scientific description of the structure, activity, and application of Recombinant Human CEMIP.

Structure of Recombinant Human CEMIP

Recombinant Human CEMIP is a 120 kDa protein that consists of 1023 amino acids. It is composed of multiple domains, including a signal peptide, a transmembrane domain, and a cytoplasmic tail. The extracellular region of CEMIP contains a C-type lectin domain, a mucin-like domain, and a von Willebrand factor A domain. These domains play a crucial role in cell adhesion and migration.

Activity of Recombinant Human CEMIP

Recombinant Human CEMIP is primarily known for its role in cell migration and invasion. It is expressed in various cells, including epithelial cells, fibroblasts, and immune cells. This protein has been shown to promote cell migration by interacting with integrins and promoting the formation of focal adhesions. It also plays a crucial role in the epithelial-mesenchymal transition (EMT), a process that is essential for cancer metastasis.

Apart from its role in cell migration, Recombinant Human CEMIP has also been implicated in other biological processes. It has been shown to regulate cell proliferation, survival, and apoptosis. It also plays a role in angiogenesis and wound healing. Additionally, CEMIP has been reported to modulate the immune response by regulating the activation and migration of immune cells.

Application of Recombinant Human CEMIP

Recombinant Human CEMIP has shown potential for various applications in the field of biotechnology and medicine. One of the major applications of this protein is in cancer research. Its role in promoting cell migration and invasion makes it a potential target for cancer therapy. In fact, studies have shown that inhibiting CEMIP expression can reduce cancer cell invasion and metastasis.

Apart from cancer, Recombinant Human CEMIP has also shown promise in wound healing and tissue regeneration. Its role in promoting cell migration and angiogenesis makes it a potential therapeutic agent for promoting tissue repair. Additionally, CEMIP has also been studied for its potential in modulating the immune response in diseases such as autoimmune disorders and infections.

Recombinant Human CEMIP is also widely used as an antigen for antibody production. Its high expression in cancer cells and its role in promoting cell migration and invasion make it an ideal target for cancer-specific antibodies. These antibodies can be used for diagnostic purposes and targeted therapy.

Conclusion

Recombinant Human CEMIP is a protein with diverse biological functions. Its role in cell migration and invasion, as well as its potential in cancer therapy, wound healing, and immune modulation, make it a promising target for further research and development. With its unique structure and activity, Recombinant Human CEMIP has the potential to contribute to various fields of biotechnology and medicine.

ProteoGenix catalogue number ARO-P13224. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 14.79 kDa; Fragment: Thr31-Lys166; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
CEMIP, Cell migration-inducing and hyaluronan-binding protein, KIAA1199
Host species
E. coli
Source organism
Human
Molecular weight
14.79 kDa
Sequence fragment
Thr31-Lys166
Sequence
TVAAGCPDQSPELQPWNPGHDQDHHVHIGQGKTLLLTSSATVYSIHISEGGKLVIKDHDEPIVLRTRHILIDNGGELHAGSALCPFQGNFTIILYGRADEGIQPDPYYGLKYIGVGKGGALELHGQKKLSWTFLNK
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P13224
UniProt accession
Q8WUJ3
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£235.00£188.00